Tight control of glycaemia in critically ill patients

Purpose of reviewThis manuscript attempts to review the effects associated with hyperglycaemia in critically ill patients and the effects of various insulin regimens. The available clinical findings and pertinent experimental data are examined. Recent findingsIntensive insulin therapy titrated to maintain blood glucose level between 4.4 and 6.1 mmol/l during intensive care unit stay has recently been shown to significantly decrease mortality, septic morbidity, sepsis-related organ failure, transfusion requirements and polyneuropathies. Prior studies have already documented that hyperglycaemia on admission is related to susceptibility to infections and worse outcomes following myocardial and cerebral ischaemic events. Additional effects of insulin, unrelated to the control of glycaemia, have also been reported. SummaryIntensive insulin therapy is probably warranted in most categories of critically ill patients, although some of the underlying mechanisms of its beneficial effects still need to be elucidated.

[1]  B A Mizock,et al.  Alterations in fuel metabolism in critical illness: hyperglycaemia. , 2001, Best practice & research. Clinical endocrinology & metabolism.

[2]  H. Gerstein,et al.  Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview , 2001, Stroke.

[3]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[4]  D. Chinkes,et al.  Association of hyperglycemia with increased mortality after severe burn injury. , 2001, The Journal of trauma.

[5]  H. Knobler,et al.  The role of hyperglycemia in acute stroke. , 2001, Archives of neurology.

[6]  J. Cornel,et al.  Impaired glucose metabolism predicts mortality after a myocardial infarction. , 2001, International journal of cardiology.

[7]  M. Molitch,et al.  Endocrine problems in the chronically critically ill patient. , 2001, Clinics in chest medicine.

[8]  D. Herndon,et al.  The Effects of Hyperglycemia on Skin Graft Survival in the Burn Patient , 2000, Annals of plastic surgery.

[9]  H. Gerstein,et al.  Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.

[10]  A. Rovlias,et al.  The influence of hyperglycemia on neurological outcome in patients with severe head injury. , 2000, Neurosurgery.

[11]  S. Geerlings,et al.  Immune dysfunction in patients with diabetes mellitus (DM). , 1999, FEMS immunology and medical microbiology.

[12]  M. Tseng,et al.  The Glucose Paradox in Cerebral Ischemia: New Insights , 1999, Annals of the New York Academy of Sciences.

[13]  L. Rydén,et al.  Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. , 1999, Diabetes care.

[14]  H Wedel,et al.  Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .

[15]  M. Beach,et al.  Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. , 1999, Anesthesia and analgesia.

[16]  K. Alberti,et al.  Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). , 1999, Stroke.

[17]  G. Grunkemeier,et al.  Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. , 1999, The Annals of thoracic surgery.

[18]  H. Adams,et al.  Acute blood glucose level and outcome from ischemic stroke , 1999, Neurology.

[19]  F. Logerfo,et al.  Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia. , 1998, Journal of vascular surgery.

[20]  Farris K. Timimi,et al.  Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. , 1998, Circulation.

[21]  A. Imrich,et al.  Immunologic effects of acute hyperglycemia in nondiabetic rats. , 1997, JPEN. Journal of parenteral and enteral nutrition.

[22]  G. Grunkemeier,et al.  Glucose control lowers the risk of wound infection in diabetics after open heart operations. , 1997, The Annals of thoracic surgery.

[23]  B. Tranmer,et al.  Insulin reduction of cerebral infarction due to transient focal ischemia. , 1995, Journal of neurosurgery.

[24]  P. Pozzilli,et al.  Infections and Diabetes: Mechanisms and Prospects for Prevention , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[25]  R. Traystman,et al.  Special issues: Glucose and the brain , 1992, Critical care medicine.

[26]  R. Fietsam,et al.  Complications of coronary artery surgery in diabetic patients. , 1991, The American surgeon.

[27]  M. Hostetter,et al.  The iC3b receptor on Candida albicans: subcellular localization and modulation of receptor expression by glucose. , 1990, The Journal of infectious diseases.

[28]  C. Nelson,et al.  Inhibition of Polymorphonuclear Leukocyte Respiratory Burst by Elevated Glucose Concentrations in Vitro , 1989, Diabetes.

[29]  Nielson Cp,et al.  Inhibition of Polymorphonuclear Leukocyte Respiratory Burst by Elevated Glucose Concentrations in Vitro , 1989 .

[30]  R. Andrassy,et al.  Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. , 1989, The Journal of trauma.

[31]  I. Whishaw,et al.  Postischemic insulin reduces spatial learning deficit following transient forebrain ischemia in rats. , 1989, Stroke.

[32]  G. Keusch,et al.  Infection and diabetes: the case for glucose control. , 1982, The American journal of medicine.

[33]  A. Malhotra,et al.  Stress-induced hyperglycemia. , 2001, Critical care clinics.

[34]  D. Chinkes,et al.  A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. , 1999, Annals of surgery.